Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.52 |
| ▸ | RYR2 | Q92736 | 6/20 | 0.50 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.48 |
| ▸ | NAMPT | P43490 | 4/20 | 0.48 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.43 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.43 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15989340 | 0.86 | ESR1 (0.53) | ESR1ESR2RYR2ROCK1NAMPT | |
| SCHEMBL31463192 | 0.82 | RYR2 (0.57) | ESR1ESR2RYR2ROCK1NAMPT | |
| SCHEMBL15880544 | 0.81 | ESR1 (0.57) | ESR1ESR2RYR2ROCK1NAMPT | |
| SCHEMBL30677763 | 0.81 | ESR1 (0.57) | ESR1ESR2RYR2ROCK1NAMPT | |
| SCHEMBL14590586 | 0.81 | ESR1 (0.57) | ESR1ESR2RYR2ROCK1NAMPT | |
| SCHEMBL6234508 | 0.80 | ESR1 (0.51) | ESR1ESR2RYR2ROCK1NAMPT | |
| SCHEMBL30142489 | 0.80 | RYR2 (0.62) | ESR1ESR2RYR2ROCK1NAMPT | |
| SCHEMBL30685160 | 0.80 | DPP8 (0.52) | NAMPTHSP90AA1TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL27356900 | 0.80 | DPP8 (0.52) | NAMPTHSP90AA1TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL31463281 | 0.79 | RYR2 (0.51) | ESR1ESR2RYR2ROCK1NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353833-A1 | DPP9 BINDING COMPOUNDS | UNIV ANTWERPEN (BE) | 2025-11-20 | — | — | US | disclosed |
| WO-2023233024-A1 | DPP9 BINDING COMPOUNDS | UNIVERSITEIT ANTWERPEN (BE) | 2023-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353833-A1 | DPP9 BINDING COMPOUNDS | DPP9, DPP7, DPP3 | ESR1 2582/4885ESR2 2371/4885RYR2 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.